Related Experiment Video

Updated: Aug 10, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Combination therapy for acute myocardial infarction: glycoprotein IIb/IIIa inhibitors plus thrombolysis

C P Cannon1

  • 1Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA.

Clinical Cardiology
|September 24, 1999
PubMed

Insights

Combining glycoprotein IIb/IIIa receptor inhibitors with reduced-dose thrombolytic therapy shows promise for improving early artery patency in acute myocardial infarction (MI) patients without increasing bleeding risk.

Area of Science:

  • Cardiology
  • Pharmacology
  • Emergency Medicine

Background:

  • Thrombolytic therapy is crucial for acute ST-segment elevation myocardial infarction (MI).
  • Newer thrombolytic agents have not improved early reperfusion rates.
  • Aspirin is an effective adjunctive agent in acute MI management.

Purpose of the Study:

  • To investigate the efficacy of combining platelet glycoprotein (GP) IIb/IIIa receptor inhibitors with thrombolytic agents.
  • To determine if this combination enhances platelet inhibition and clinical outcomes in acute MI.
  • To evaluate improved angiographic and clinical efficacy compared to standard thrombolytic therapy.

Main Methods:

  • Review of emerging experimental and clinical data.
  • Analysis of findings from the Thrombolysis in Myocardial Infarction (TIMI)-14 trial.
  • Focus on combining GP IIb/IIIa receptor inhibition with reduced-dose thrombolytic therapy.

Main Results:

  • Combining GP IIb/IIIa receptor inhibition with reduced-dose thrombolytic therapy improves early infarct-related artery patency.
  • This combination strategy does not appear to increase bleeding risk.
  • Emerging data suggest enhanced platelet inhibition and clinical efficacy.

Conclusions:

  • There is a strong clinical and physiologic rationale for combining GP IIb/IIIa receptor inhibitors with reduced-dose fibrinolytic agents in acute MI.
  • Clinical investigation is focusing on this combined approach for acute ST-segment elevation MI.
  • This strategy holds potential for improving treatment efficacy in acute myocardial infarction.

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...